The present invention provides methods of treating neurological disorders in a mammal by administering to the mammal an effective amount of a selective persistent sodium channel antagonist that has at least 20-fold selectivity for persistent sodium current relative to transient sodium current.

 
Web www.patentalert.com

< Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity

< Phenoxymethylalkyne inhibitors of LTA4H for treating inflammation

> Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis

> Methods of making medical devices
~ 00611